Exam 4 - Lec 64 ADHD Ott Flashcards
____ of children with ADHD will have the diagnosis in adulthood
a. 1/4
b. 1/3
c. 1/2
b. 1/3
which of the following is FALSE about ADHD?
a. higher rate if diagnosed in a first degree relative
b. etiology is multifactorial (environmental, genetics, physiological)
c. dec risk of substance use and antisocial personality disorder if ADHD left untreated
c. dec risk of substance use and antisocial personality disorder if ADHD left untreated
(it would be increased)
which of the following is FALSE about ADHD diagnostic criteria?
a. for each sx domain, must have at least 6 sx present
b. for ages 17 and up, at least 5 sx are required for either of the two specifiers
c. several inattentive or hyperactive sx must be present prior to age 10
d. sx are present in 2 or more settings
c. several inattentive or hyperactive sx must be present prior to age 10
(prior to age 12)
look at slide 8 and 9 for sx of inattention and hyperactivity
ok
T or F: for stimulant dosing, we calculate pediatric pts based on mg/kg
F (variations in dosing not found to be due to height or weight)
IR stimulants are preferred for pts weighing < ___ kg due to limited low-dose availability of LA stimulants
< 16 kg
T or F: for stimulant dosing, late afternoon sx may require longer-acting formulation
T
T or F: pts can take an amphetamine-based and methylphenidate-based stimulant at the same time
F
Mydayis is indicated for pts age ___ and up
13
Mydayis dose for ages 13-17
a. 25 mg/day
b. 12.5 mg/day
b. 12.5 mg/day
what is the formulation for Daytrana?
patch
what medication is a prodrug that is converted to dextroamphetamine?
a. Mydayis
b. Daytrana
c. Vyvanse
d. Jornay PM
c. Vyvanse
when should a Jornay PM dose be taken?
in the evening between 6:30-9:30 pm (helps with morning problems)
which of the following are NOT considered common AE’s of stimulants?
a. stomach ache
b. insomnia
c. hallucinations
d. reduced appetite
e. risk for sudden cardiac death
f. jitteriness
c, e (these ones are uncommon)
if a pt experiences hallucinations from a stimulant, how should we manage it?
a. reduce dose
b. d/c stimulant and reassess diagnosis
c. divide dose, give with food
d. switch formulation
b. d/c stimulant and reassess diagnosis